| Independent Reports (Showing 1 to 10 of 26) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 19-Jun-13 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Large CAP Pharma | 17 | $195.50 | View Abstract |
| 18-Jun-13 | Datamonitor | Datamonitor PLC | AstraZeneca PLC | 76 | $175 | View Abstract |
| 18-Jun-13 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - ASTRAZENECA PLC (AZN-LN) | 11 | $25 | View Abstract |
| 17-Jun-13 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | View Abstract |
| 15-Jun-13 | S&P Capital IQ – STARS Reports | N/A | AstraZeneca ADS | 10 | $115 | View Abstract |
| 15-Jun-13 | Reuters Investment Profile | N/A | AstraZeneca PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | View Abstract |
| 15-Jun-13 | Reuters Investment Profile | N/A | Arcturus Ventures Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | View Abstract |
| 15-Jun-13 | Pechala's Reports | Frantisek Pechala | ASTRA ZENECA PLC (AZN) 12-months forecast | 1 | $15 | View Abstract |
| 14-Jun-13 | Reuters Investment Profile | N/A | AstraZeneca PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | View Abstract |
| 14-Jun-13 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (Europe) | 69 | $793.50 | View Abstract |